Podcasts about frcsc

Send us Fan MailIn this special episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Jean Carruthers MD, FRCSC, FRC(Ophth), the pioneer of cosmetic botox, world Renowned cosmetic surgeon & award winning researcher. What began as an unexpected patient interaction ultimately changed the way the world thinks about facial aging, leading to the development of cosmetic botulinum toxin treatments that continue to shape the field today.Dr. Carruthers reflects on the remarkable journey from treating patients with functional eye disorders to recognizing an entirely new application for botulinum toxin. At a time when cosmetic options for expression lines were limited, the idea of selectively relaxing muscles to soften wrinkles represented a completely new approach. Yet the path from observation to acceptance was far from easy. Early presentations were met with skepticism, and it was rigorous research, clinical evidence, and persistence that ultimately transformed a controversial idea into one of the most extensively studied treatments in aesthetic medicine.Throughout the conversation, Dr. Carruthers emphasizes the role of curiosity in scientific discovery. Many breakthroughs, she explains, emerge not from certainty but from paying attention to unexpected outcomes and asking better questions. That mindset continues to guide her perspective on the future of aesthetics, from preventative treatments and regenerative medicine to emerging technologies that may change how outcomes are measured and understood.More than a history lesson, this episode offers a rare glimpse into the mindset behind true innovation. Listen to the full episode to hear Dr. Jean Carruthers share the story behind the discovery that revolutionized aesthetics, her perspective on the future of regenerative medicine, and why the most important tool in science may be an open mind.Read about Dr. Jean CarruthersDon't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

In this episode, Jamie Wilson, MD, FRCS, MSc interviews Christopher Ahuja, MD, PhD, FRCSC, FAANS and Michael Fehlings, MD, PhD, FRCSC, about the challenges of sustaining a research career alongside a demanding spine surgery practice. They discuss how long timelines for scientific discovery, frequent setbacks in research, and competing clinical responsibilities can contribute to burnout. The conversation highlights strategies for maintaining motivation, including focusing on incremental progress, setting meaningful milestones, and protecting time for work, family, and personal well-being.

Lateral Extra-Articular Tenodesis (LET) has become an accepted adjunct to standard anterior cruciate ligament reconstruction to help provide additional rotational stability to the knee and lower the risk of re-tears. The classic situation to perform this surgery would be at the same time as an ACL reconstruction in a patient with a high degree of rotational instability or in a patient who has already had ACL surgery and re-torn. However, might there be a role for LET performed as a standalone procedure? A subset of patients following ACL surgery will have a knee that is very stable in the anterior-to-posterior (front-to-back) direction but continues to demonstrate some degree of rotational instability. Could an LET performed in isolation provide these patients with that additional rotational stability and thus lower their risk of another injury, or is that a crazy idea? Click here to read the article.

Please visit answersincme.com/NYR860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jill Liss, MD, MSCP; Denise Black, MD, FRCSC; and Danielle Covarrubias. In this activity, experts in women's health, joined by a patient advocate, discuss the burden of menopause-related vasomotor symptoms (VMS) and novel management strategies. Upon completion of this activity, participants should be better able to: Identify the impact and burden of VMS as a consequence of menopause; Outline the clinical rationale for novel therapeutic approaches to manage menopause-related VMS; Evaluate the efficacy and safety of novel neurokinin-targeted therapies for treating menopause-related VMS; and Implement patient-centered clinical approaches to improve outcomes for patients experiencing menopause-related VMS.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027.The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

At the 2025 AAHKS Annual Meeting, our host William B. Kurtz, MD had the great opportunity to sit with Michael E. Neufeld, MD, MSc, FRCSC whose study Synovial Metal Ions in “Nickel Free” vs. Standard Cobalt-Chrome Containing Total Knee Replacement won the James A. Rand, MD Young Investigator's Award.  It was a case-controlled study, consisting of 22 patients with metal allergies and 19 controls with patients that underwent standard knee replacement with cobalt-chrome containing knees. What made this study so fascinating is that implants are hypoallergenic, containing no nickel in them, however Dr. Neufeld’s study found that nickel content in the hypoallergenic knee was four times higher than the standard cobalt-knee. So, our host and Dr. Neufeld discuss all possible explanations for why in this study implants had higher nickel in the synovial fluid.  Listen and learn what their hypothesizes were for this. Be sure to subscribe and thanks for listening to AAHKS Amplified! In This Episode:William B. Kurtz, MDMichael E. Neufeld, MD, MSc, FRCSC The post The 2025 James A. Rand, MD Young Investigator's Award Goes to Presentation on “Nickel Free” vs. Standard Cobalt-Chrome first appeared on AAHKS.

At the 2025 AAHKS Annual Meeting, our host William B. Kurtz, MD had the great opportunity to sit with Michael E. Neufeld, MD, MSc, FRCSC whose study Synovial Metal Ions in “Nickel Free” vs. Standard Cobalt-Chrome Containing Total Knee Replacement won the James A. Rand, MD Young Investigator's Award.  It was a case-controlled study, consisting of 22 patients with metal allergies and 19 controls with patients that underwent standard knee replacement with cobalt-chrome containing knees. What made this study so fascinating is that implants are hypoallergenic, containing no nickel in them, however Dr. Neufeld’s study found that nickel content in the hypoallergenic knee was four times higher than the standard cobalt-knee. So, our host and Dr. Neufeld discuss all possible explanations for why in this study implants had higher nickel in the synovial fluid.  Listen and learn what their hypothesizes were for this. Be sure to subscribe and thanks for listening to AAHKS Amplified! In This Episode:William B. Kurtz, MDMichael E. Neufeld, MD, MSc, FRCSC The post The 2025 James A. Rand, MD Young Investigator's Award Goes to Presentation on “Nickel Free” vs. Standard Cobalt-Chrome first appeared on AAHKS.

Please visit answersincme.com/DZU860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Michelle Jacobson, MD, MHSc, FRCSC, MSCP; Nadia Harbeck, MD, PhD; and Renate Haidinger. In this activity, experts in breast cancer and menopause discuss the burden of vasomotor symptoms (VMS) due to breast cancer treatment and the emerging role of neurokinin (NK) receptor antagonists in alleviating these symptoms in practice, with insights from a patient advocate. Upon completion of this activity, participants should be better able to: Recognize VMS as a consequence of breast cancer treatment; Outline the clinical rationale for novel therapeutic approaches to manage VMS associated with breast cancer treatment; Evaluate the efficacy and safety of NK receptor antagonists for breast cancer treatment–associated VMS; and Implement patient-centered clinical approaches to elevate the quality of life of patients experiencing breast cancer–associated VMS.

What happens when the physician who helped introduce Botox to the world reflects on how far aesthetics has come? Dr. Jean Carruthers shares the unexpected moment that changed everything, and why it still shapes how she thinks about facial rejuvenation today. She talks through the early days of skepticism, how botulinum toxin A evolved from treating frown lines to influencing everything from jawline slimming to scar healing, and why precision and restraint matter more now than ever. What started as a simple observation became a global shift in how we approach aging. Looking ahead, Dr. Carruthers explains what excites her most about the future of aesthetics, from skin quality treatments to scar prevention, and why customization, safety, and long-term patient trust will always outlast trends. About Jean Carruthers, MD, FRCSC, FRC Dr. Jean Carruthers is a globally recognized pioneer in cosmetic surgery and non-invasive aesthetic procedures, with unparalleled expertise in both research and clinical practice. Together with her husband, Dr. Alastair Carruthers, she revolutionized the cosmetic industry by pioneering the use of botulinum A exotoxin ("Botox"), a treatment that has since become the most widely performed cosmetic procedure worldwide. Learn more about cosmetic surgery pioneer Dr. Jean Carruthers Follow Dr. Carruthers on Instagram @carrutherscosmetic About Dr. Lawrence Bass Innovator. Industry veteran. In-demand Park Avenue board certified plastic surgeon, Dr. Lawrence Bass is a true master of his craft, not only in the OR but as an industry pioneer in the development and evaluation of new aesthetic technologies. With locations in both Manhattan (on Park Avenue between 62nd and 63rd Streets) and in Great Neck, Long Island, Dr. Bass has earned his reputation as the plastic surgeon for the most discerning patients in NYC and beyond. To learn more, visit the Bass Plastic Surgery website or follow the team on Instagram @drbassnyc Subscribe to the Park Avenue Plastic Surgery Class newsletter to be notified of new episodes & receive exclusive invitations, offers, and information from Dr. Bass. 

Last year at the 2025 AAHKS Annual Meeting, our host William B. Kurtz, MD spoke with the James A. Rand, MD, Young Investigator’s Award recipient Michael E. Neufeld, MD, MSc, FRCSC about his study on Synovial Metal Ions in “Nickel Free” vs. Standard Cobalt-Chrome Containing Total Knee Replacement.  Dr. Neufeld shared that the aim of his study was to compare intraarticular synovial fluid levels of metal ions in patients who underwent cemented primary TKA with a hypoallergenic implant vs. a matched cohort of standard cobalt-chromium (Co-Cr) containing implants at a minimum two-year follow-up. A case-controlled study was conducted using prospectively collected data from a single institution – 22 cases and 19 controls.  Interestingly, the study uncovered that patients with hypoallergenic implants had intraarticular synovial Ni ion levels 3.6 times higher vs. standard implant controls, contesting the use of this hypoallergenic implant for Ni allergy/hypersensitivity. Listen to the full discussion and make sure you click subscribe! Thanks for listening to AAHKS Amplified! In This Episode: William B. Kurtz, MD Michael E. Neufeld, MD, MSc, FRCSC The post Synovial Metal Ions in Nickel Free vs. Standard Cobalt-Chrome Containing Total Knee Replacement first appeared on AAHKS.

Last year at the 2025 AAHKS Annual Meeting, our host William B. Kurtz, MD spoke with the James A. Rand, MD, Young Investigator’s Award recipient Michael E. Neufeld, MD, MSc, FRCSC about his study on Synovial Metal Ions in “Nickel Free” vs. Standard Cobalt-Chrome Containing Total Knee Replacement.  Dr. Neufeld shared that the aim of his study was to compare intraarticular synovial fluid levels of metal ions in patients who underwent cemented primary TKA with a hypoallergenic implant vs. a matched cohort of standard cobalt-chromium (Co-Cr) containing implants at a minimum two-year follow-up. A case-controlled study was conducted using prospectively collected data from a single institution – 22 cases and 19 controls.  Interestingly, the study uncovered that patients with hypoallergenic implants had intraarticular synovial Ni ion levels 3.6 times higher vs. standard implant controls, contesting the use of this hypoallergenic implant for Ni allergy/hypersensitivity. Listen to the full discussion and make sure you click subscribe! Thanks for listening to AAHKS Amplified! In This Episode: William B. Kurtz, MD Michael E. Neufeld, MD, MSc, FRCSC The post Synovial Metal Ions in Nickel Free vs. Standard Cobalt-Chrome Containing Total Knee Replacement first appeared on AAHKS.

Editor Choice:  Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trialHosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta CanadaFeaturing: Janice S. Kwon  MD, MPH, FRCSC, University of British Columbia, Vancouver, Canada and  R. Wendel Naumann, MD Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 28203, USAhttps://www.gynecologiconcology-online.net/article/S0090-8258(26)00001-6/https://www.gynecologiconcology-online.net/article/S0090-8258(26)00789-4/Check out more content on the journal's homepage at https://www.gynecologiconcology-online.net

Rachel Soyoun Kim, MD, MHSc, FRCSC - From Evidence to Practice: Combining Immunotherapy With Chemoradiotherapy Regimens in Locally Advanced Cervical Cancer

Please visit answersincme.com/PME860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) discuss strategies for optimizing the detection and management of CRSwNP, with a focus on the role of biologics in patient-centered care. Upon completion of this activity, participants should be better able to: Identify best practices to facilitate the early detection of CRSwNP; Discuss the risk-benefit profiles of approved and emerging biologics for the treatment of CRSwNP; and Identify patient-centered, multidisciplinary strategies to integrate biologics into the treatment algorithm for patients with CRSwNP.

AUA2025: Key Takeaways: BPH Presenters: Bilal Chughtai, MD & Dean S. Elterman, MD, MSc, FRCSC

Today we're joined by Dr. Ashley Brissette, MD, MSc, FRCSC—award-winning NYC ophthalmologist, cataract and refractive surgeon, dry-eye specialist, and team ophthalmologist for the New York Rangers—for a no-nonsense guide to modern eye health and your beauty routine. She also happens to be Clinique's Guiding Opthamologist and works with the brand to help educate beauty lovers (like us!) on the importance of eye safety when using makeup products. We dig into the biggest myths around “sensitive eyes,” how to cleanse lids without wrecking your barrier, what the label “ophthalmologist tested” actually entails, and her favorite products like Clinique's Take the Day Off Cleansing Balm, High Impact High-Fi™ Full Volume Mascara, and High Impact Gel Tech Eyeliner. Shop this episodeWatch our episodes!CALL or TEXT US: 424-341-0426Instagram: @glossangelspod, @kirbiejohnson, @saratanTwitter: @glossangelespod, @kirbiejohnson, @saratanEmail: glossangelespodcast@gmail.com Hosted on Acast. See acast.com/privacy for more information.

In the second episode of the four-part Quality Improvement (QI) Project Guide series, Martin A. Koyle MD, MSc, MMgmt, MBA(cert.), FAAP, FACS, FRCSC, FRCS (Eng.), FRSM, and Kara Watts, MD, join Andrew Harris, MD, MBA, Chair of AUA's Quality Improvement and Patient Safety (QIPS) Committee, for a conversation on AUA's new QI Project Guide. They discussed the planning phase of a QI project and how strong preparation can set a project up for success.

Michael G. Fehlings, MD, PhD, FRCSCRajiv Saigal, MD, PhDYi Lu, MD, PhDBrian K. Kwon, MD, PhD, FRCSC

This episode features a fireside chat with Ajit K. Sachdeva, MD, FACS, FRCSC, who led the ACS Division of Education for more than 24 years. Dr. Sachdeva describes his early career as a surgeon, his practice in Philadelphia, and his long tenure creating innovative educational programming for surgeons around the world. The program host is Mohsen M. Shabahang, MD, PhD, FACS, for the ACS Academy of Master Surgeon Educators.   Talk about the podcast on social media using the hashtag #HouseofSurgery.

In the world of hip and knee replacements, many advancements have been made to make surgeries more successful for patients. For this, we are internally grateful, however there’s one thing that all orthopaedic surgeons try to avoid that can make a routine procedure a nightmare – INFECTION! In this episode, we have Michael Blankstein, MD, MSc, FRCSC, Antonia F. Chen, MD, MBA and Nicolas S. Piuzzi, MD who all have done extensive research on the prevention and dealing with infection speak openly about how infections can start, the different types of infections patients can develop and how it can drastically impact a patient’s life and their love ones. Infections are very serious, and prevention is key, but with approximately 800k total knee replacements done each year in the US and 550k hip replacements, the two percent chance of one of those patients developing an infection causes major issues for the patient, their love ones and the surgeon. Although the numbers for patients with infections have decreased over time, surgeons should still be very cautious – only operating on patients who are medically optimized to avoid the possibility of infection. In this episode, our surgeons discuss the two different types of infections (acute and chronic) and how to differentiate between the two. If you are considering a hip or knee replacement, you don’t want to miss this podcast recording.  Enjoy, and thanks for listening to AAHKS Amplified! In This Episode: Michael Blankstein, MD, MSc, FRCSC Antonia F. Chen, MD, MBA Nicolas S. Piuzzi, MD The post Infections first appeared on AAHKS.

David G. Deckey, MD a member of the AAHKS Patient and Public Relations Committee moderated a very liberating conversation on returning to physical activity following arthroplasty surgery. Dr. Deckey was joined by Jason M. Jennings, MD, DPT, Ivan M. Tomek, MD, FRCSC and physical therapist Philip McKelvy, PT, DPT. In this episode, listeners will enjoy a full-on discussion from experts in the field of arthroplasty on their recommendations of when and how patients should return to activity that falls within moderate to high activity levels. Learn about limitations, the key to educating patients to avoid possibly injury and what physical activity is ideal during the healing process.  If you are considering a hip or knee replacement, you don’t want to miss this podcast recording, no matter your personal activity level. There’s something for everyone, regardless of your activity level.  Enjoy, and thanks for listening to AAHKS Amplified! In This Episode: David G. Deckey, MD Jason M. Jennings, MD, DPT Philip McKelvy, PT, DPT Ivan M. Tomek, MD, FRCSC The post Returning to Sports After Arthroplasty first appeared on AAHKS.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP In addition to heavy menstrual bleeding, patients with uterine fibroids often deal with many other considerable effects on their physical and mental wellbeing. To provide optimal care, it's important to recognize the full impact of fibroids, communicate carefully about treatment options, and promote equitable access to care. Dr. Charles Turck sits down with Dr. Ayman Al-Hendy to learn more about how we can address the multifaceted burden of uterine fibroids. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP In addition to heavy menstrual bleeding, patients with uterine fibroids often deal with many other considerable effects on their physical and mental wellbeing. To provide optimal care, it's important to recognize the full impact of fibroids, communicate carefully about treatment options, and promote equitable access to care. Dr. Charles Turck sits down with Dr. Ayman Al-Hendy to learn more about how we can address the multifaceted burden of uterine fibroids. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Despite longstanding reliance on surgery, recent advancements have reshaped our approach to uterine fibroids. However, common myths and misconceptions have limited the adoption of newer therapies, leaving many patients unaware of their available options. Join Dr. Charles Turck and Dr. Ayman Al-Hendy as they explain shifting treatment paradigms and patient education strategies in uterine fibroid care. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP Despite longstanding reliance on surgery, recent advancements have reshaped our approach to uterine fibroids. However, common myths and misconceptions have limited the adoption of newer therapies, leaving many patients unaware of their available options. Join Dr. Charles Turck and Dr. Ayman Al-Hendy as they explain shifting treatment paradigms and patient education strategies in uterine fibroid care. Dr. Al-Hendy is a Professor of Obstetrics and Gynecology and the Director of Translational Research at the University of Chicago Pritzker School of Medicine.

Shannon Salvador, MD, MSc, FRCSC - Advancing Frontline Endometrial Cancer Care: Translating the Latest Advances in Immunotherapy Plus Chemotherapy Regimens to Practice

Denise Black, MD, FRCSC / Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, MSCP - Navigating the Menopause Transition With Your Patients: Experts Answer Key Questions

Alon Altman, MD, FRCSC, CCPE - It Takes Two: Integrating Immunotherapy in Combination With Chemotherapy Into Recurrent or Primary Advanced Endometrial Cancer Care

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder Co-Host: Anne Pelletier Cameron, MD, FRCSC, URPS Segment #1: Is this an update to the prior Guideline? Segment #2: What is new in the Diagnosis, ntitial Assessment and Initial Management of OAB? Segment#3: What does the Guideline say about Oral Medication? Segment #4: What's new in minimally invasive prodcedures Segment #5: UDS and Cystoscopy Segment #6: What is new and exciting on the horizion for OAB Segment #7: Where to start and the most impactpact research in this area The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. Published online April 23, 2024. doi:10.1097/JU.0000000000003985. https://www.auajournals.org/doi/10.1097/JU.0000000000003985

Linda Lee, MD, FRCPC / Jacob Rullo, MD, PhD, FRCSC - Managing MEK-Inhibitor–Associated Retinopathy in Metastatic Melanoma: An Expert Discussion

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJW865. CME/MOC/AAPA/IPCE credit will be available until November 8, 2025.Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc, Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Editor in Chief Cecelia E. Schmalbach, MD, MSc, is joined by senior author Julie E. Strychowsky MD, MAS, FRCSC, and Associate Editor Michael J. Brenner, MD, to discuss methods for improving the efficiency of ORs for surgeons as outlined in the paper “Improving Operating Room Efficiency in Otolaryngology–Head and Neck Surgery: A Scoping Review” which published in the October 2024 issue of Otolaryngology–Head and Neck Surgery. They discuss the importance of finding ways to save time and cost for operating rooms in order to serve more patients and reduce physician burnout. Click here to read the full article.    

Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology Featuring: Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada Dr Scott Glaser, MD, City of Hope, USA

Ask the Experts: New Guidelines in Spinal Cord Injury Brian K. Kwon, MD, PhD, FRCSC; Michael G. Fehlings, MD, PhD, FRCSC; Rajiv Saigal, MD, PhD; Yi Lu, MD, PhD

Dr. James A. Simon is a highly accomplished and respected physician dedicated to advancing research and clinical care in women's sexual and reproductive health. This is his second appearance on our Menopause Reimagined Podcast. The link to his first interview can be found below. We posted a short video, and our viewers asked many questions. So Andrea Donsly, nutritionist, menopause researcher, menopause educator, and co-found of Morphus, invited Dr. Simon back to answer all your questions about Urinary Tract Infections.

In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and management of the future liver remnant. This is part one of a two-part series.

In this episode of SurgOnc Today®, Julie Hallet, MD, MSc, FRCSC, FSSO, from the University of Toronto and Vice-Chair of the SSO HPB disease site working group is joined by Stefano Partelli, MD, PhD, from Università Vita-Saluta San Raffaele and Els Nieveen van Dijkum, MD, PhD, from Amsterdam UMC. We will delve into the rationale behind the non-operative management of non-functional sporadic pancreatic neuroendocrine tumors (PNETs) as well as the design and results of two prospective studies, ASPEN and PANDORA. Show Notes: PANDORA: https://academic.oup.com/bjs/article/108/8/888/6202974 ASPEN (interim analysis): https://academic.oup.com/bjs/article/109/12/1186/6672718?login=false

I was recently honored to be a guest speaker among the innovators, stakeholders, and pioneering minds in managing benign prostate hyperplasia at the annual assembly of the Society of Benign Prostate Disease, held in Dallas this February.  Today, I am delighted to have one of the Society of Benign Prostate Disease board of directors, Dr. Kevin Zorn, joining me to share an insider perspective as we review the key takeaways from the meeting and bring you up to speed on the latest technologies for evaluating and managing BPH. We will also offer a sneak peek into several new advancements coming down the pipeline.  Dr. Kevin Zorn, from the BPH Canada Clinic in Montreal, is a board-certified urologist and former Associate Professor of Urology at the Universities of Montreal and Chicago, sub-specializing in robotic surgery and BPH surgical care. Throughout his career, Dr. Zorn has been committed to research and innovation. He was the first in Canada and Quebec to use many new BPH technologies, including Greenlight XPS, Rezum, ITind, Optilume, and aquablation. Dr. Zorn is a senior author of the BPH guidelines for the Canadian Urological Association, having authored 345 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care. He has lectured, taught, and practiced surgery globally and is intimately involved in developing several new pioneering BPH technologies. Stay tuned for the latest insights and breakthroughs as we unveil the future of BPH management. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Zorn shares some highlights from his presentation on the evaluation of BPH in the modern clinic setting How new technology, like mobile apps and point-of-care ultrasound, can improve the diagnosis and treatment times for BPH Explanation of the UroCuff technology Discussion of the latest technology that has been available over the last year for interventional management of BPH The importance of knowing the personal preferences of patients when selecting their treatment options for BPH The benefits of aquablation technology Dr. Zorn discusses the evolution of BPH treatment Why urologists must remain flexible in their approach to BPH care The importance stay up-to-date with the latest BPH technology and guidelines The potential of AI to empower urologists and improve patient care Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. BPH Canada  Society of Benign Prostate Disease

This week the fellas have the pleasure of speaking with Sean Christie, MD, FRCSC, a renowned neurosurgeon and expert in making operating rooms more environmentally sustainable. Sean is a professor, vice chair, and director of research at the division of neurosurgery at Dalhousie University. Operating rooms are known to generate large amounts of waste and consume significant amounts of energy and resources. Sean shares with us his insights on the importance of creating more eco-conscious operating rooms and the benefits it can bring not only to the environment but also to patient care and hospital finances. Through his expertise and experience, Sean demonstrates how making operating rooms more eco-friendly can have a significant impact on reducing the healthcare industry's environmental footprint and promoting a healthier and more sustainable future for all. Join the post-episode conversation over on Discord! https://discord.gg/expeUDN